24 U A B C O M P R E H E N S I V E C A N C E R C E N T E R 25





The Alfred F. LoBuglio Distinguished Faculty Award

Fouad Receives Top Cancer Center Research Award

MONA FOUAD, M.D., M.P.H., director of the UAB Minority Health and Health Disparities Research Center (MHRC), has become the first

woman to receive the UAB Comprehensive Cancer Center s Albert F.

LoBuglio Distinguished Faculty Award for outstanding contributions to

the research mission of the center.

The award was presented by Edward Partridge, M.D., Cancer Center

director, at the center s annual research retreat. Named for Albert F.

LoBuglio, M.D., who served as the Cancer Center s director for 21 years,

the award is presented annually to a Cancer Center investigator for out-

standing research contributions.

It is clear why Mona Fouad was selected for this honor, Dr.

Partridge says. She has been a co-

leader of the center s Cancer Control and

Population Sciences Program for many

years and has been the most influential

person in establishing our Cancer Center

as a national leader in cancer disparities research. She has also been a

leader in creating a training program for minority scientists and other

investigators interested in a career in cancer disparities research.

Under Dr. Fouad s leadership, the UAB MHRC has brought to UAB

more than $100 million in extramural grant funding over the past 10

years, most of it to improve health and prevent disease in minorities.




the UAB Comprehensive Cancer Center

as a professor in the UAB Department of

Epidemiology, where she will hold the

Caldwell Marks Endowed Chair in Molecular


Dr. Skibola received her bachelor s

degree in nutrition and her Ph.D. in environ-

mental health sciences from the University

of California-Berkeley. She remained at

UC-Berkeley for much of her following

career, most recently serving as an asso-

ciate adjunct professor in the school s

Department of Environmental Health

Sciences prior to joining the faculty at UAB.

Dr. Skibola s research primarily focuses

on identifying the ways genetic variation and

environmental exposures contribute to the

development of human B-cell lymphomas

and leukemias, and determining the mecha-

nisms involved. In 2011, she was honored

with the Award for Outstanding Service to

the InterLymph Consortium, an open, inter-

national scientific forum for epidemiologic

research in non-Hodgkin s lymphoma.

HARRY P. ERBA, M.D., PH.D., has joined the UAB Division of Hematology and Oncology as the new director of hematologic malignancies and a senior scien- tist in the UAB Comprehensive Cancer Center experi- mental therapeutics program.

Dr. Erba is a highly respected leader in the field of hematologic malignancies the types of cancer that affect blood, bone marrow, and lymph nodes par- ticularly regarding the assessment of novel therapies in acute myeloid and chronic myeloid leukemias and

myelodysplastic syndromes.  Dr. Erba has served on National Comprehensive Cancer Network Practice

Guidelines committees for acute myeloid and chronic myeloid leukemias, myelo- dysplastic syndromes and myeloid growth factors and was appointed to the NCCN Board of Producers in 2007 and 2008. He also has been an executive officer of SWOG, a leading cancer research network, since 2006, working closely with the leadership of its leukemia, lymphoma, myeloma and bone marrow transplant commit- tees; he will chair the leukemia committee beginning in October 2012.

After attending Yale University, Dr. Erba received his medical and doctoral degrees from Stanford University and completed his internship and residency in internal medi- cine at the Brigham and Women s Hospital at Harvard Medical School. Following a fellowship in hematology/oncology at the same institution, he joined the Harvard Medical School faculty for three years until he moved to the University of Michigan in Ann Arbor, where he was an associate professor.

Renowned Blood Cancer Specialist Joins Cancer Center